{'fraction_non_alphanumeric': 0.012429378531073447, 'fraction_numerical': 0.006779661016949152, 'mean_word_length': 5.068493150684931, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Advocacy group sees little progress toward an HIV vaccine.


 The AIDS Vaccine Advocacy Group issued a report on May 15 claiming that both the pharmaceutical industry and the United States government have made little progress towards the development of an HIV vaccine. President Clinton set a goal of 2007 for a vaccine, but the Advocacy Group states that a viable vaccine will not be available by then, due to a lack of coordination and leadership. While Federal funding has increased for vaccine research, the pharmaceutical industry has scaled back or eliminated many HIV vaccine research programs. The Advocacy Group has proposed that policy makers take a more direct role to encourage vaccine research, develop financial incentives for vaccine research, begin planning for global access to an HIV vaccine, and prevent discrimination against volunteers in vaccine clinical trials.
